ecrin-mdr-crcClinical2006Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2019754United States3CapecitabineBevacizumabECRIN MDRCompletedfalseBevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal CancerThe purpose of this study is to evaluate the safety and effectiveness of the bevacizumab and capecitabine combination in frail patients with untreated metastatic colorectal cancer.2006-03-152019754NCT00203411